FIELD: chemistry.
SUBSTANCE: invention relates to a process for the preparation of a compound of general formula (I) and pharmaceutically acceptable salts thereof from an amine of formula (II) using urea of formula (III) as the synthesis intermediate. According to the disclosed process, urea of formula (III) is prepared from an amine of formula (II) according to the following steps: (1) reacting an amine of formula (II) and Cl3CC(O)-N=C=O to obtain a compound having formula (IV); (2) treating, in an alkaline medium, the compound of formula (IV) obtained in the previous step to obtain a urea of formula (III). Compound of formula (I) is then obtained from the urea of formula (III) via Shestakov regrouping. Invention also relates to a process for the preparation of a compound of formula (V) and a compound of formula (III). In the formulae (I) - (V) G1 is a link, A is an aryl group, such as phenyl substituted in the para position with a (C5-10)aryl-(C1-6)alkyl group, and B is an aryl group such as phenyl substituted in the ortho position with a heterocycle, such as a piperidin-1-yl group, and substituted in ortho'-position by an alkyl group, such as methyl. , , , , .
EFFECT: method enables to prepare hydrazines of formula (I), which can be used in the synthesis of compounds of formula (V), used in the treatment of infection caused by the papilloma virus.
8 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF PAPILLOMAVIRUS INHIBITOR | 2013 |
|
RU2661007C2 |
TETRAHYDROPIRIMIDINE-2-ON DERIVATIVES AND THEIR APPLICATION | 2003 |
|
RU2334741C2 |
USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
HETEROCYCLIC COMPOUNDS | 2006 |
|
RU2383539C2 |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS | 2009 |
|
RU2477281C2 |
METHOD FOR ASYMMETRICAL HYDROGENATION OF ACRYLIC ACID DERIVATIVES, CATALYSED BY TRANSITION METALS, AND NOVEL CATALYST SYSTEM FOR ASYMMETRICAL CATALYSIS WITH TRANSITION METALS | 2005 |
|
RU2415127C2 |
THERAPEUTIC DRUG OR PREVENTIVE THERAPEUTIC AGENT FOR DIABETIC NEPHROPATHY | 2017 |
|
RU2735538C1 |
DERIVATIVES OF (THIO)UREA INHIBITING VIIa FACTOR, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2286337C2 |
3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR | 2004 |
|
RU2358970C2 |
PYRIDAZINONE DERIVATIVES AND METHODS OR PREPARING THEREOF | 1996 |
|
RU2131419C1 |
Authors
Dates
2018-03-29—Published
2013-12-27—Filed